Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells.

The present study examined how the multidrug resistance protein (MRP1), which is an ATP-dependent anionic conjugate transporter, also mediates the transport of reduced glutathione (GSH) and the co-transport of the cationic drug, daunorubicin, with GSH in living GLC4/Adr cells. To obtain information on the affinity of GSH for the multidrug resistance protein in GLC4/Adr cells, we investigated the GSH concentration dependence of the ATP-dependent GSH efflux. The intracellular GSH concentration was modulated by preincubation of the cells with 25 microM buthionine sulfoximine, an inhibitor of GSH synthetase, for 0-24 h. The transport of GSH was related to the intracellular GSH concentration up to approximately 5 mM and then plateaued. Fitting of the obtained data according to the Michaelis-Menten equation revealed a Km of 3.4+/-1.4 mM and a Vmax of 1.5+/-0.2x10(-18) mol/cell/s. The ATP-dependent transport of GSH was inhibited by 3-([[3-(2-[7-chloro-2-quinolinyl]ethenyl)phenyl]-[(3-dimethylamino-3-oxopropyl)-thio]-methyl]thio)propanoic acid (MK571), with 50% inhibition being obtained with 1.4 microM MK571. We investigated the GSH concentration dependence of the MRP1-mediated ATP-dependent transport of daunorubicin under conditions where the transport of daunorubicin became saturated. The daunorubicin transport was related to the intracellular GSH concentration up to approximately 5 mM and then plateaued. We were therefore in the situation where GSH acted as an activator: its presence was necessary for the binding and transport of daunorubicin by MRP1. However, GSH was also transported by the multidrug resistance protein. The concentration of GSH that gave half the maximal rate of daunorubicin efflux was 2.1+/-0.8 mM, very similar to the Km value obtained for GSH. In conclusion, the rate of daunorubicin efflux, under conditions where the transport of daunorubicin became saturated, and the rate of GSH efflux determined at any intracellular concentration of GSH were very similar, yielding a 1:1 stoichiometry with respect to GSH and daunorubicin transport. These results support a model in which daunorubicin is co-transported with GSH.

[1]  S. Cole,et al.  Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. , 1996, Biochemical pharmacology.

[2]  F. DuBru,et al.  Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells. , 1998, Molecular pharmacology.

[3]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[4]  D. Hipfner,et al.  Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.

[5]  T. Furukawa,et al.  Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P. , 1997, Molecular pharmacology.

[6]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[8]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[9]  N. Mulder,et al.  Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. , 1987, Cancer research.

[10]  F. Russel,et al.  Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells. , 1999, Molecular pharmacology.

[11]  D. Keppler,et al.  Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.

[12]  T. Uchiumi,et al.  Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2) , 1999, FEBS letters.

[13]  D. Ettori,et al.  Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein. , 1999, Biochimica et biophysica acta.

[14]  W. Priebe,et al.  P‐glycoprotein‐mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells , 1994, FEBS letters.

[15]  J. Lankelma,et al.  The effect of glutathione on the ATPase activity of MRP1 in its natural membranes , 2000, FEBS letters.

[16]  D. Keppler,et al.  ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. , 1996, The Biochemical journal.

[17]  A. Garnier-Suillerot,et al.  Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells. , 1994, European journal of biochemistry.

[18]  F. Frézard,et al.  Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells. , 1991, European journal of biochemistry.

[19]  P. Jansen,et al.  ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1 , 1999, British journal of pharmacology.

[20]  N. Kaplowitz,et al.  The use of monochlorobimane to determine hepatic GSH levels and synthesis. , 1990, Analytical biochemistry.

[21]  V. Ling,et al.  Mechanism of multidrug resistance. , 1988, Biochimica et biophysica acta.

[22]  F. DuBru,et al.  Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. , 1996, Molecular pharmacology.

[23]  S. Cole,et al.  Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. , 1996, The Journal of biological chemistry.

[24]  S. Cole,et al.  Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. , 1998, Cancer research.

[25]  G. Kruh,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0527 MOAT-E (ARA) is a full-length MRP/cMOAT subfamily , 2022 .

[26]  J. S. Brand,et al.  Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme system. , 1975, Analytical biochemistry.

[27]  R. Evers,et al.  Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione , 1999 .

[28]  S. Cole,et al.  ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells. , 1999, Biochimica et biophysica acta.

[29]  R. Scheper,et al.  Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. , 1995, British Journal of Cancer.

[30]  F. Frézard,et al.  Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and -sensitive K562 cells. , 1991, Biochimica et biophysica acta.

[31]  F. Baas,et al.  Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Garnier-Suillerot,et al.  Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. , 2000, European journal of pharmacology.

[33]  A. Garnier-Suillerot,et al.  Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells. , 1994, Biochimica et biophysica acta.